对充血性心力衰竭患者单次及多次服用控释片后普瑞特罗的药代动力学研究。 - Suppr

Suppr

超能文献

Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.

作者信息

Dahlström U, Graffner C, Jonsson U, Hoffmann K J, Karlsson E, Lagerström P O

出版信息

Eur J Clin Pharmacol. 1983;24(4):495-502. doi: 10.1007/BF00609892.

DOI:10.1007/BF00609892

PMID:6861864

Abstract

摘要

相似文献

Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.对充血性心力衰竭患者单次及多次服用控释片后普瑞特罗的药代动力学研究。

Eur J Clin Pharmacol. 1983;24(4):495-502. doi: 10.1007/BF00609892.

Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.

Acta Med Scand Suppl. 1982;659:89-98. doi: 10.1111/j.0954-6820.1982.tb00838.x.

Effects of prenalterol in congestive heart failure.普瑞特罗在充血性心力衰竭中的作用。

Eur Heart J. 1982 Dec;3 Suppl D:115-21.

Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.肼屈嗪以及肼屈嗪与普瑞特罗联合治疗对充血性心力衰竭患者的短期和长期影响。

Acta Med Scand Suppl. 1982;659:315-24. doi: 10.1111/j.0954-6820.1982.tb00856.x.

Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.

Am J Med. 1984 Jun;76(6):999-1005. doi: 10.1016/0002-9343(84)90848-9.

Effects of prenalterol administered orally in patients with congestive heart failure.

Acta Med Scand Suppl. 1982;659:201-20. doi: 10.1111/j.0954-6820.1982.tb00848.x.

Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.普瑞特罗，一种口服β-1肾上腺素能受体激动剂，用于治疗慢性心力衰竭。

Eur J Clin Pharmacol. 1983;25(4):539-45. doi: 10.1007/BF00542125.

The pharmacokinetics of oral and intravenous prenalterol in young, healthy volunteers.年轻健康志愿者口服和静脉注射普瑞特罗的药代动力学。

Biopharm Drug Dispos. 1986 Jan-Feb;7(1):47-52. doi: 10.1002/bdd.2510070107.

Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.对慢性重症心力衰竭患者进行β1 激动剂普瑞特罗的急性静脉注射和持续口服治疗。

Br Heart J. 1984 May;51(5):530-8. doi: 10.1136/hrt.51.5.530.

Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.静脉注射普瑞特罗对重度心力衰竭患者的血流动力学影响。

Acta Med Scand Suppl. 1982;659:221-31. doi: 10.1111/j.0954-6820.1982.tb00849.x.

引用本文的文献

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒：EXTRIP 工作组的系统评价和建议。

Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.

Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).心力衰竭患者药物的临床药代动力学：最新进展（第2部分，口服给药）

Clin Pharmacokinet. 2014 Dec;53(12):1083-114. doi: 10.1007/s40262-014-0189-3.

Effects of food on clinical pharmacokinetics.食物对临床药代动力学的影响。

Clin Pharmacokinet. 1999 Sep;37(3):213-55. doi: 10.2165/00003088-199937030-00003.

Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure.

Eur J Clin Pharmacol. 1985;28(4):397-403. doi: 10.1007/BF00544357.

Effects of cardiovascular disease on pharmacokinetics.心血管疾病对药代动力学的影响。

Cardiovasc Drugs Ther. 1989 Oct;3(5):711-30. doi: 10.1007/BF01857622.

Clinical pharmacokinetics of beta-agonists.β-激动剂的临床药代动力学

Clin Pharmacokinet. 1990 Apr;18(4):270-94. doi: 10.2165/00003088-199018040-00002.

本文引用的文献

Compartment model of prenalterol.

Acta Med Scand Suppl. 1982;659:99-107. doi: 10.1111/j.0954-6820.1982.tb00839.x.

Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.

Acta Med Scand Suppl. 1982;659:89-98. doi: 10.1111/j.0954-6820.1982.tb00838.x.

The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans.选择性β1肾上腺素能受体激动剂普瑞特罗在小鼠、大鼠、犬和人类体内的代谢情况。

Drug Metab Dispos. 1982 Mar-Apr;10(2):173-9.

Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.选择性β1肾上腺素能受体激动剂普瑞特罗在人体的药代动力学研究。

Eur J Clin Pharmacol. 1981;20(2):91-7. doi: 10.1007/BF00607143.

Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.口服普瑞特罗对人体的血流动力学影响、血浆浓度及耐受性

Eur J Clin Pharmacol. 1980 Nov;18(5):383-90. doi: 10.1007/BF00636789.

Studies on a sustained release principle based on an inert plastic matrix.基于惰性塑料基质的缓释原理研究。

Acta Pharm Suec. 1971 Jun;8(3):153-68.

Pharmacokinetic of procainamide in man.普鲁卡因酰胺在人体中的药代动力学。

Ann N Y Acad Sci. 1971 Jul 6;179:370-82. doi: 10.1111/j.1749-6632.1971.tb46914.x.

Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.利多卡因在人类晚期心力衰竭、肝脏疾病和肾衰竭中的药代动力学。

Ann Intern Med. 1973 Apr;78(4):499-508. doi: 10.7326/0003-4819-78-4-499.

Absorption of alprenolol in man from tablets with different rates of release.不同释放速率的阿普洛尔片剂在人体中的吸收情况。

Acta Pharm Suec. 1971 Mar;8(1):59-70.

Pharmacokinetics in patients with cardiac failure.心力衰竭患者的药代动力学。

Clin Pharmacokinet. 1976 Nov-Dec;1(6):389-405. doi: 10.2165/00003088-197601060-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验